XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Additional
Paid-in
Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   154,332,366    
Beginning balance at Dec. 31, 2023 $ 55,558 $ 1 $ 327,280 $ (271,723)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common shares issued upon vesting of restricted share units, net of withholding (in shares)   2,895,489    
Common shares issued upon vesting of restricted share units, net of withholding (98)   (98)  
Share-based compensation 842   842  
Net loss (9,634)     (9,634)
Ending balance (in shares) at Mar. 31, 2024   157,227,855    
Ending balance at Mar. 31, 2024 46,668 $ 1 328,024 (281,357)
Beginning balance (in shares) at Dec. 31, 2023   154,332,366    
Beginning balance at Dec. 31, 2023 55,558 $ 1 327,280 (271,723)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (26,478)      
Ending balance (in shares) at Sep. 30, 2024   157,762,229    
Ending balance at Sep. 30, 2024 30,243 $ 1 328,443 (298,201)
Beginning balance (in shares) at Mar. 31, 2024   157,227,855    
Beginning balance at Mar. 31, 2024 46,668 $ 1 328,024 (281,357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common shares issued upon vesting of restricted share units, net of withholding (in shares)   267,187    
Common shares issued upon vesting of restricted share units, net of withholding (20)   (20)  
Share-based compensation 237   237  
Net loss (11,057)     (11,057)
Ending balance (in shares) at Jun. 30, 2024   157,495,042    
Ending balance at Jun. 30, 2024 35,828 $ 1 328,241 (292,414)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common shares issued upon vesting of restricted share units, net of withholding (in shares)   267,187    
Common shares issued upon vesting of restricted share units, net of withholding (15)   (15)  
Share-based compensation 217   217  
Net loss (5,787)     (5,787)
Ending balance (in shares) at Sep. 30, 2024   157,762,229    
Ending balance at Sep. 30, 2024 $ 30,243 $ 1 328,443 (298,201)
Beginning balance (in shares) at Dec. 31, 2024 158,009,541 158,009,541    
Beginning balance at Dec. 31, 2024 $ 27,087 $ 1 328,655 (301,569)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation 187   187  
Net loss (6,212)     (6,212)
Ending balance (in shares) at Mar. 31, 2025   158,009,541    
Ending balance at Mar. 31, 2025 $ 21,062 $ 1 328,842 (307,781)
Beginning balance (in shares) at Dec. 31, 2024 158,009,541 158,009,541    
Beginning balance at Dec. 31, 2024 $ 27,087 $ 1 328,655 (301,569)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (18,318)      
Ending balance (in shares) at Sep. 30, 2025 159,136,454 159,136,454    
Ending balance at Sep. 30, 2025 $ 9,247 $ 1 329,133 (319,887)
Beginning balance (in shares) at Mar. 31, 2025   158,009,541    
Beginning balance at Mar. 31, 2025 21,062 $ 1 328,842 (307,781)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common shares issued upon vesting of restricted share units, net of withholding (in shares)   608,226    
Common shares issued upon vesting of restricted share units, net of withholding (25)   (25)  
Share-based compensation 180   180  
Net loss (6,288)     (6,288)
Ending balance (in shares) at Jun. 30, 2025   158,617,767    
Ending balance at Jun. 30, 2025 14,929 $ 1 328,997 (314,069)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common shares issued upon vesting of restricted share units, net of withholding (in shares)   518,687    
Common shares issued upon vesting of restricted share units, net of withholding (9)   (9)  
Share-based compensation 145   145  
Net loss $ (5,818)     (5,818)
Ending balance (in shares) at Sep. 30, 2025 159,136,454 159,136,454    
Ending balance at Sep. 30, 2025 $ 9,247 $ 1 $ 329,133 $ (319,887)